Literature DB >> 12360563

Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease.

Joanna Seniów1, Thomas Bak, Jolanta Gajda, Renata Poniatowska, Anna Czlonkowska.   

Abstract

We sought to determine the pattern of cognitive deficits in patients with Wilson's disease (WD) with different type and degree of neurological involvement, and to interpret the findings in relation to the underlying pathology. A total of 67 WD patients were examined with a neuropsychological test battery assessing different aspects of cognitive processing. The patients were subdivided into three groups: neurologically asymptomatic, neurological with pure basal ganglia lesions, and neurological with more extensive pathology. The results were compared with 50 matched healthy controls. Patients with a neurological form of WD showed a mild but definitive impairment in all cognitive functions. In contrast, the neurologically asymptomatic patients showed no deficits when compared with normal controls. Multifocal pathology was associated with more severe cognitive deficits than selective basal ganglia lesions but did not contribute significantly to memory impairment. A range of cognitive functions, including frontal-executive ability, aspects of memory and visuospatial processing, are affected in the neurologically symptomatic WD patients. In contrast, no subliminal deficits were observed in the asymptomatic patients. The lesions of the basal ganglia seem to be of central importance in explaining the symptomatology. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 12360563     DOI: 10.1002/mds.10195

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

Review 1.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

Review 2.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

3.  Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease.

Authors:  T Litwin; G Gromadzka; J Samochowiec; A Grzywacz; A Członkowski; A Członkowska
Journal:  JIMD Rep       Date:  2012-07-06

4.  Possible Effects of Copper and Ceruloplasmin Levels on Auditory Event Potentials in Boys with Attention Deficit Hyperactivity Disorder.

Authors:  Özgür Yorbik; Caner Mutlu; Mehmet Fatih Özdağ; Abdullah Olgun; Gül Eryilmaz; Semih Ayta
Journal:  Noro Psikiyatr Ars       Date:  2016-09-20       Impact factor: 1.339

5.  Complex psychiatric presentation in adolescent onset Wilson's disease.

Authors:  S Woerwag-Mehta; Peter Hindley; Tammy Hedderly; Anil Dhawan
Journal:  BMJ Case Rep       Date:  2011-01-11

6.  Category and perceptual learning in subjects with treated Wilson's disease.

Authors:  Pengjing Xu; Zhong-Lin Lu; Xiaoping Wang; Barbara Dosher; Jiangning Zhou; Daren Zhang; Yifeng Zhou
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

8.  The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.

Authors:  Bradleigh D Hayhow; Islam Hassan; Jeffrey C L Looi; Francesco Gaillard; Dennis Velakoulis; Mark Walterfang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-08-26

9.  Basal ganglia-orbitofrontal circuits are associated with prospective memory deficits in Wilson's disease.

Authors:  Sheng Hu; ChunSheng Xu; Yi Wang; Ting Dong; Hongli Wu; Anqin Wang; Chuanfu Li; BenSheng Qiu
Journal:  Brain Imaging Behav       Date:  2021-07-23       Impact factor: 3.978

10.  Selective impairment of attentional networks of alerting in Wilson's disease.

Authors:  Yongsheng Han; Fangfang Zhang; Yanghua Tian; Panpan Hu; Bo Li; Kai Wang
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.